A business that supports manufacturers from materials design to manufacturing optimization through an “MI/PI integrated platform” that combines physics-based models with AI. By leveraging high-precision modeling and technologies that make underlying reasoning visible, it addresses the challenges of materials development and mass production that have been difficult to solve with conventional AI, aiming to create a world where desired materials can be mass-produced exactly as designed through computation.
Planning, operation, management, and implementation of training, courses, and seminars on robotics and related technologies.Consulting and contract development for robot manufacturing ／ Research and development of robot hardware and software ／ Production and sales of educational content regarding robotics and related technologies ／ Development of information systems and electronic equipment
A startup developing 3D game-based medical devices to comprehensively assess and treat executive function in children with ADHD. By combining game design with neuroscience, it advances digital transformation in healthcare and expands possibilities for supporting diverse children.
We are a company dedicated to the social implementation of molecular simulation technologies developed in the Washizu Laboratory at the University of Hyogo. Our office is located on the University of Hyogo campus in Kobe’s Port Island, adjacent to the supercomputer Fugaku. We currently provide analysis and R&D support using large-scale molecular simulations, and we are also developing a molecular–fluid coupled simulator as well as mesoscale simulators for material surfaces based on particle methods.
Our mission is to “transform infectious disease care and become the flagship company solving the antimicrobial resistance crisis.” We develop medical devices and AI solutions to accelerate, standardize, and optimize infectious disease treatment. Through AI and automation technology, we promote the appropriate use of antibiotics, working to reduce deaths caused by drug-resistant bacteria and mitigate economic losses.